Please login to the form below

Not currently logged in
Email:
Password:

ThermiGen appoints Vladimir Paul-Blanc as president

He will also serve as the Almirall-owned firm's general manager

Vladimir_Paul-BlancMedical aesthetics technology firm ThermiGen has appointed Vladmir Paul-Blanc as its president and general manager.

Paul-Blanc’s new role at the firm, which was acquired by Spanish pharma company Almirall in 2016, will see him focus on driving short and long term revenues and goals through global operations, marketing, sales and coordination of business development activities.

He previously served Solta Medical - the aesthetics energy device division of Valeant Pharmaceuticals – as its general manager.

He said: “I couldn’t be more excitied to join Almirall and work with the Thermi organisation.

“The entire leadership team has done an extremely impressive job establishing Thermi products in the aesthetic energy-based devises category.

“I look forward to joining the team immediately and contributing to future growth and success.”

Paul-Blanc succeeds both Thermi’s previous CEO Paul Herchman and Kevin O’Brien, Thermi’s previous president, who move on to new roles as global strategic advisors to the Thermi board.

24th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics